We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.
CA 19-9 has been shown to be raised in: Pancreatic adenoncarcinomas (most) Gastric carcinomas (50%) Colorectal carcinomas (30%) CA 19-9 should not
A significant proportion (25-30%) of patients with advanced breast cancer have tumours which do not produce CA 15-3.
samples from healthy females (pre and post-menopausal) yielded a value of 35 kU/L (95th percentile). kU/L = U/mL Further information Lab Tests Online: CA